FCBT
ADMA icon

First Citizens Bank & Trust’s ADMA Biologics ADMA Stock Holding History

First Citizens Bank & Trust’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
44,347
-117
-0.3% -$1.07K 0.01% 520
2026
Q1 		$401K Sell
44,464
-4,299
-9% -$67.8K 0.01% 482
2025
Q4 		$889K Buy
48,763
+9,576
+24% +$161K 0.02% 310
2025
Q3 		$574K Sell
39,187
-863
-2% -$14.8K 0.01% 404
2025
Q2 		$729K Buy
40,050
+26,752
+201% +$546K 0.01% 339
2025
Q1 		$264K Buy
+13,298
New +$230K 0.01% 408

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

First Citizens Bank & Trust's ADMA Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its ADMA Biologics (ADMA) stake by 0.26% in Q2 2026, selling an estimated $1.07K and leaving 44,347 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #520.

First Citizens Bank & Trust first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $889K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • First Citizens Bank & Trust held 44,347 shares of ADMA Biologics worth $371K as of Q2 2026.
  • First Citizens Bank & Trust sold 117 ADMA Biologics shares in Q2 2026, an estimated $1.07K.
  • ADMA Biologics made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #520 holding.
  • First Citizens Bank & Trust first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • First Citizens Bank & Trust's ADMA Biologics position peaked at $889K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.